Nexalin Technology, Inc. (NXL)
NASDAQ: NXL · Real-Time Price · USD
1.380
-0.010 (-0.72%)
At close: Nov 20, 2026, 4:00 PM EST
1.370
-0.010 (-0.72%)
After-hours: Nov 20, 2026, 7:28 PM EST
Nexalin Technology Market Cap
Nexalin Technology has a market cap or net worth of $1.71 million as of November 20, 2026. It is the 48,302nd most valuable company in the world and the 6,405th biggest in the United States. Its market cap has decreased by 91.29% in one year.
Market Cap
1.71M
Enterprise Value
2.14M
1-Year Change
-91.29%
Global Rank
Country Rank
#6,405 United States
Category
ChartMarket Cap Chart
Since the IPO on September 16, 2022, Nexalin Technology's market cap has decreased from $16.38M to $1.71M, a decrease of -89.58%. That is a compound annual growth rate of -41.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.71M | -83.60% |
| Dec 31, 2025 | 10.41M | -70.68% |
| Dec 31, 2024 | 35.50M | 1,079.21% |
| Dec 29, 2023 | 3.01M | -44.79% |
| Dec 30, 2022 | 5.45M | -66.71% |
| Sep 16, 2022 (IPO) | 16.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| VolitionRx | 2.34M |
| 20/20 Biolabs | 2.31M |
| Autonomix Medical | 2.13M |
| INVO Fertility | 2.10M |
| Bluejay Diagnostics | 2.01M |
| Profusa | 1.96M |
| Co-Diagnostics | 1.73M |
| Beyond Air | 1.69M |